Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025GenesOpen Access

Does BRCA Mutation Status Influence Ovarian Cancer Onset Timing and Patients’ Treatment Outcomes?

View Full Paper
Ask AI
Bookmark
Share

Authors

KMKaja MichalczykAMAgata MokrzyckaMRMarianna Rudzińska

Discussion

Loading...

Member takes

Overview

Retrospective analysis reveals BRCA mutations influence ovarian cancer onset age, suggesting implications for treatment outcomes.

Key Points

  • Patients with BRCA mutations were diagnosed with ovarian cancer at a younger age, highlighting genetic influence.
  • BRCA1 mutation led to improved overall survival compared to non-carriers, indicating its favorable prognostic role.
  • Survival analysis showed no difference in progression-free survival between BRCA carriers and non-carriers, suggesting treatment uniformity.
  • Findings emphasize the importance of BRCA status in ovarian cancer prognostics and support further research for validation.

Cite This Study

Michalczyk et al. (2025) studied this question.

synapsesocial.com/papers/68c1ae7054b1d3bfb60e6554https://doi.org/10.3390/genes16080883
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Frequency of BRCA1 Dysfunction in Ovarian Cancer2002 · 140 citations
  2. 2Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study2022 · 319 citations
  3. 3ClinVar: public archive of interpretations of clinically relevant variants2015 · 2,958 citations
  4. 4Comparison of Survival Outcomes According toBRCA1/2Variant Type in High-grade Serous Ovarian Cancer2022 · 2 citations
  5. 5A prognostic model for ovarian cancer2001 · 187 citations